Actualité en rhumatologie 2020 : l’accent a été mis sur le Covid-19 [Rheumatology update 2020: the focus was on Covid-19]
Fiche du document
27 janvier 2021
- doi: 10.53738/REVMED.2021.17.723.0214
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.723.0214
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/33507664
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_92029461F0668
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
TherapyCiter ce document
T. Hügle, « Actualité en rhumatologie 2020 : l’accent a été mis sur le Covid-19 [Rheumatology update 2020: the focus was on Covid-19] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.723.0214
Métriques
Partage / Export
Résumé
In 2020, clinical studies have opened the way for several new treatment options in rheumatoid arthritis, psoriasis arthritis, spondylarthritis and lupus. However, this year was mainly characterized by the Covid-19 pandemic which had a substantial impact on rheumatology. The initial fear for immune-compromised patients undergoing more severe Covid-19 courses remained without evidence. The same was true for the hype of several rheumatic treatments such as Plaquenil or anti-IL-6 blockade which finally did not show efficacy in prospective trials for Covid-19 pneumonia. On the other side, notably the first confinement had a substantial negative impact on rheumatic patients. Our patients are still struggling with the consequences of prolonged immobilization, lack of physiotherapy, missing consultations and treatment adaption as well as social isolation and depression. Telemedicine and upcoming digital solutions compensated this gap at least partially. The post-Covid syndrome with persisting fibromyalgia-like symptoms potentially will join the spectrum of rheumatic disorders.